New insights in staging tools, surgical, and medical management of stage II-III ...
Prof Alexander M. M. Eggermont, Erasmus University, Rotterdam, The Netherlands
23 Sep 2009
ECCO 15 - ESMO 34 News 23rd September 2009
Prof Gordon McVie - ecancer Managing Editor
23 Sep 2009
ANTI-CTLA-4: A new immunological approach
Dr Jeff Weber, Moffitt Cancer Center, Tampa, Florida, USA
23 Sep 2009
Panel discussion and final conclusions
New approaches in advanced melanoma
23 Sep 2009
Two treatments for advanced melanoma show significant improvements in overall su...
Dr Paul Chapman - Memorial Sloan-Kettering Cancer Center, USA
23 Sep 2009
Current Challenges in the Treatment of Advanced Melanoma
Prof Axel Hauschild - University of Kiel, Germany
23 Sep 2009
ECCO 15 - ESMO 34 News 22nd September 2009
Prof Gordon McVie - ecancer Managing Editor
22 Sep 2009
ECCO 15 - ESMO 34 News 20-21 September, 2009
Prof Gordon McVie - ecancer Managing Editor
21 Sep 2009
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Why attend ECCO 15 - ESMO 34?
22 Jul 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key iss...
ECCO 15 - ESMO 34
22 Jul 2009
Therapeutic vaccine improves response rate and extends progression-free survival...
Dr Patrick Hwu - M.D. Anderson Cancer Center, US
3 Jul 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
14 May 2009
